Nath Bio-Genes (India) Limited

Nath Bio-Genes (India) Limited (NATHBIOGEN) is a micro-cap Fast Moving Consumer Goods company valued at ₹263 crore operating in Other Agricultural Products on the NSE and BSE.

Recent price move

Nath Bio-Genes (India) Limited last traded at ₹140, modestly up 1.68% on the day.

Recent developments

On 2026-10-02, the company submitted an audio recording from its Q4 FY26 earnings call, indicating revenue growth of 19% for the quarter.

Financial performance

The company's business has grown significantly, with annual revenue rising 66.1% year-over-year. However, the net profit margin has narrowed by 5.2 percentage points to 9.4%, while net profit increased only 6.7%. The latest quarter saw revenue and net profit both rise 15.6% and 15.2% respectively compared to the same quarter a year earlier.

Valuation multiples

The stock trades at 6.4 times earnings, a discount to the Fast Moving Consumer Goods median of 19.6, 0.42 times book value. It yields 1.3%.

Things to watch

The net profit margin has declined significantly, narrowing by 5.2 percentage points to 9.4%. The return on equity is 0.0%, suggesting poor profitability relative to shareholders' equity. The stock is 32.5% below its 52-week high, indicating a notable decline from recent peak levels.

Where it stands

The company has seen strong revenue growth, but its net profit margin has deteriorated. The latest quarter showed revenue and net profit both rising 15.6% and 15.2% year-over-year. The stock is currently 32.5% below its 52-week high.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.